Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2344 of 3330
Next
>>
>
58576 to 58600 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
SUM1315MO2	TNBC	Basal B	PD 98059	MEK	MAPK	0.016	uM	10875.152	0.9320	0.8200	0.7465
SUM1315MO2	TNBC	Basal B	PD 98059	MEK	MAPK	0.08	uM	10875.152	0.9387	0.8374	0.7465
SUM1315MO2	TNBC	Basal B	PD 98059	MEK	MAPK	0.4	uM	10875.152	0.9357	0.8296	0.7465
SUM1315MO2	TNBC	Basal B	PD 98059	MEK	MAPK	2	uM	10875.152	0.9285	0.8108	0.7465
SUM1315MO2	TNBC	Basal B	PD 98059	MEK	MAPK	10	uM	10875.152	0.8728	0.6669	0.7465
SUM1315MO2	TNBC	Basal B	PD 98059	MEK	MAPK	50	uM	10875.152	0.8983	0.7323	0.7465
SUM1315MO2	TNBC	Basal B	PD 98059	MEK	MAPK	0.000128	uM	12428.152	0.9480	0.8811	0.8719
SUM1315MO2	TNBC	Basal B	PD 98059	MEK	MAPK	0.00064	uM	12428.152	0.9996	0.9990	0.8719
SUM1315MO2	TNBC	Basal B	PD 98059	MEK	MAPK	0.0032	uM	12428.152	0.9577	0.9032	0.8719
SUM1315MO2	TNBC	Basal B	PD 98059	MEK	MAPK	0.016	uM	12428.152	0.9563	0.9000	0.8719
SUM1315MO2	TNBC	Basal B	PD 98059	MEK	MAPK	0.08	uM	12428.152	0.9658	0.9218	0.8719
SUM1315MO2	TNBC	Basal B	PD 98059	MEK	MAPK	0.4	uM	12428.152	1.0128	1.0295	0.8719
SUM1315MO2	TNBC	Basal B	PD 98059	MEK	MAPK	2	uM	12428.152	1.0088	1.0203	0.8719
SUM1315MO2	TNBC	Basal B	PD 98059	MEK	MAPK	10	uM	12428.152	0.9723	0.9365	0.8719
SUM1315MO2	TNBC	Basal B	PD 98059	MEK	MAPK	50	uM	12428.152	0.8529	0.6663	0.8719
SUM149PT	TNBC	Basal B	PD 98059	MEK	MAPK	0.000128	uM	10819.152	0.9490	0.9486	2.0116
SUM149PT	TNBC	Basal B	PD 98059	MEK	MAPK	0.00064	uM	10819.152	0.9620	0.9619	2.0116
SUM149PT	TNBC	Basal B	PD 98059	MEK	MAPK	0.0032	uM	10819.152	0.9984	0.9984	2.0116
SUM149PT	TNBC	Basal B	PD 98059	MEK	MAPK	0.016	uM	10819.152	0.9981	0.9981	2.0116
SUM149PT	TNBC	Basal B	PD 98059	MEK	MAPK	0.08	uM	10819.152	1.0122	1.0121	2.0116
SUM149PT	TNBC	Basal B	PD 98059	MEK	MAPK	0.4	uM	10819.152	0.9675	0.9674	2.0116
SUM149PT	TNBC	Basal B	PD 98059	MEK	MAPK	2	uM	10819.152	0.9482	0.9478	2.0116
SUM149PT	TNBC	Basal B	PD 98059	MEK	MAPK	10	uM	10819.152	0.8869	0.8842	2.0116
SUM149PT	TNBC	Basal B	PD 98059	MEK	MAPK	50	uM	10819.152	0.7778	0.7651	2.0116
SUM149PT	TNBC	Basal B	PD 98059	MEK	MAPK	0.000256	uM	11937.159	0.9681	0.9710	2.2200

|<
<<
Previous
Page 2344 of 3330
Next
>>
>
58576 to 58600 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)